Skip to main content
Caplight Logo









Orthobond Corporation

Orthobond Corporation

Private
Monmouth Junction, New JerseyHealthcare & Life Scienceshttps://orthobond.com/

Last Round

Seed Round

Sep 1, 2026

Total Funding Raised

$292,856

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Orthobond Corporation is a biotechnology company that develops proprietary antimicrobial nanosurfaces with broad applications in the medical device industry.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

antimicrobial coatingsurface modificationmedical device coatingnanotechnologysurgical site infectionSSI preventionmedical implantbiomaterialstechnology licensingmedtechbacterial colonizationorthopedic implantsurface engineeringFDA regulatory supportinfection control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orthobond Corporation Comparables

Compare Orthobond Corporation with similar companies based on industry and business-model similarity.

Orthobond Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genetoo Inc.
85%
DeBogy Molecular, Inc.
85%
SPARTHA Medical
84%

Orthobond Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundSep 1, 2026
AcceleratorSep 12, 2024
Private PlacementJun 1, 2024
GrantApr 5, 2024
GrantApr 12, 2022
VC Round
Oct 1, 2011

Key People

Founding team and executive leadership

David Nichols

Chief Executive Officer

Executive Team

Paul Volovich

Investor Advisor To CEO

Executive Team

Orthobond Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Raised $8.3M in seed funding.

  • Jul 26, 2026

    Monthly visitors increased 243% MoM.

Orthobond Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orthobond Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orthobond Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonmouth Junction, New Jersey
Employee Range21
Year Founded2004
Last FundingSep 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?